Related Experiment Videos
Elastosis in lung carcinoma: Immunohistochemical, ultrastructural and clinical studies
M Fukushima1, Y Fukuda, M Kawamoto
1Department of Pathology, Nippon Medical School, Tokyo, Japan. mitchy@nms.ac.jp
Pathology International
|December 21, 2000
Summary
Elastosis, characterized by abnormal elastic fiber deposits, is prevalent in lung adenocarcinomas and associated with improved survival in early stages. This finding offers new insights into lung cancer pathology.
Area of Science:
- Pathology
- Oncology
- Biochemistry
Context:
- Elastosis, the accumulation of elastic fibers, is known in breast cancer but not well-documented in lung cancer.
- Primary lung carcinomas present diverse histological subtypes with varying prognoses.
Purpose:
- To investigate the characteristics and prevalence of elastosis in primary lung carcinomas.
- To correlate elastosis with histological subtypes, differentiation, and patient prognosis.
Summary:
- Elastosis was detected in 85% of adenocarcinomas, 18% of squamous cell carcinomas, and 71% of adenosquamous carcinomas, but not in small-cell or large-cell carcinomas.
- Higher elastosis scores were observed in adenocarcinoma compared to squamous cell carcinoma, and within adenocarcinoma, in well-differentiated types.
- Microscopic analysis revealed mature and immature elastic fibers positive for alpha-1-antitrypsin, suggesting both degradation and synthesis.
- No correlation was found between elastosis and tumor invasion, but early-stage adenocarcinomas (IA and IB) with elastosis showed significantly improved survival.
Impact:
- This study establishes elastosis as a significant pathological feature in lung adenocarcinoma.
- The presence of elastosis may serve as a potential prognostic biomarker for early-stage lung adenocarcinoma.
- Understanding elastosis composition may reveal novel therapeutic targets in lung cancer treatment.